Current trends and geographical differences in therapeutic profile and outcomes of COVID-19 among pregnant women - a systematic review and meta-analysis

被引：0
作者：
Pallavi Dubey
Bhaskar Thakur
Sireesha Reddy
Carla A. Martinez
Md Nurunnabi
Sharron L. Manuel
Sadhana Chheda
Christina Bracamontes
Alok K. Dwivedi
机构：
[1] Texas Tech University Health Sciences Center El Paso,Department of Obstetrics and Gynecology, Paul L. Foster School of Medicine
[2] Texas Tech University Health Sciences Center El Paso,Division of Biostatistics & Epidemiology, Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine
[3] the University of Texas at El Paso,School of Pharmacy
[4] Texas Tech University Health Sciences Center El Paso,Department of Pediatrics, Paul L. Foster School of Medicine
[5] Texas Tech University Health Sciences Center El Paso,Biostatistics and Epidemiology Consulting Lab
来源：
BMC Pregnancy and Childbirth | / 21卷
关键词：
Treatment; Hydroxychloroquine; Antivirals; Preterm birth; Antibiotics; Mechanical ventilation; ICU admission; Maternal death; Adverse pregnancy outcomes; Meta-analysis; Cesarean section;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 477 条
[1]  
Hu Y(2020)Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis J Clin Virol 127 104371-184
[2]  
Sun J(2020)SARS-CoV-2, SARS-CoV, and MERS-COV: a comparative overview Infez Med 28 174-1599
[3]  
Dai Z(2017)Risks associated with viral infections during pregnancy J Clin Invest 127 1591-775
[4]  
Deng H(2020)SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis of clinical features and pregnancy outcomes EClinicalMedicine 25 100446-3013
[5]  
Li X(2020)Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-June 7, 2020 MMWR Morb Mortal Wkly Rep 69 769-1283
[6]  
Huang Q(2020)Antiviral agent therapy optimization in special populations of COVID-19 patients Drug Des Devel Ther 14 3001-669
[7]  
Wu Y(2020)The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: a case report Case Rep Womens Health 27 e00221-501
[8]  
Sun L(2020)Emergency use authorizations during the COVID-19 pandemic: lessons from Hydroxychloroquine for vaccine authorization and approval JAMA 324 1282-2012
[9]  
Xu Y(2020)Convalescent plasma: a possible treatment protocol for COVID- 19 patients suffering from diabetes or underlying liver diseases Diabetes Metab Syndr 14 665-815
[10]  
Rabaan AA(2020)Potential role of zinc supplementation in prophylaxis and treatment of COVID-19 Med Hypotheses 144 109848-132
12345678910